Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized trial of donepezil for visuospatial abilities in mild cognitive impairment
KCT0006236Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of donepezil in Mild Cognitive Impairment (MCI), sponsored by Eisai Co., Ltd.. Started Jul 2021; status: completed.
02
Drugs
donepezil
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on KCT0006236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006236.